Sequana Announces First Commercial Implant of its Device for Treatment of Liver Ascites
By Daniella Parra Sequana Medical said the first implantation of the alfapump in the U.S....
Editorial
Imviva Biotech to Present Treatment Updates for Leukemia & Anemia at ASH 2025
By Karen Roman Imviva Biotech said it will present its progress in allogenic cell therapy...
From Boots on the Ground to AI in the Sky: Investing in the Drone Defense Supercycle – Thematic Report
Download the Complete Report Here By Brandon Hornback From the war in Ukraine to tension...
Vinson & Elkins Announces New Partners & Counsel Class of 2026
By Karen Roman Vinson & Elkins made known the full list of its 10 lawyers...
BCG Shreds Expectations and Delivers Top-Down Beat – Quarterly Update Report
Download the Complete Report Here By Brandon Hornback Binah Capital Group, Inc. (NASDAQ: BCG) delivered...
GrabAGun Aims for Revenue Growth and Hits the Bullseye – Quarterly Update Report
Download the Complete Report Here By Brandon Hornback Donald Trump Jr.-backed GrabAGun Digital Holdings Inc....
Trends in Stressed and Distressed Sectors: Octus Head of Special Situations Jared Muroff, Live at Nasdaq
Tech Edge hosted a fireside chat on Nov. 17 from the Nasdaq Marketsite with Jared...
Yubo Raises Minimum Age to 18 as Social Discovery Platform Evolves With Gen Z User Base
The platform that brought Gen Z together during the pandemic is making a strategic shift,...
Security Meets AI Robots: Fireside with Knightscope CEO William Santana Li
IPO Edge hosted a fireside chat with Knightscope, Inc. (Nasdaq: KSCP) on Nov. 13 to...
FDA Recognizes March Biosciences’ MB-105 with RMAT Status
By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class...
© Copyright 2025, ExecEdge